Wee L. Chin

15 Hospital Ave
Nedlands, WA 6009, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

TIME in motion: How response takes shape.

TIME in motion: How response takes shape.

Journal: Cancer cell
Published: June 11, 2026

Update on pleural mesothelioma.

Update on pleural mesothelioma.

Journal: Current opinion in pulmonary medicine
Published: April 15, 2026

Mesothelioma location influences the tumour microenvironment and immune checkpoint therapy response in preclinical models.

Mesothelioma location influences the tumour microenvironment and immune checkpoint therapy response in preclinical models.

Journal: Scientific reports
Published: November 03, 2025

GeneInsight: Condensing gene set knowledge via language models.

GeneInsight: Condensing gene set knowledge via language models.

Journal: PLoS computational biology
Published: September 02, 2025

SampleExplorer: using language models to discover relevant transcriptome data.

SampleExplorer: using language models to discover relevant transcriptome data.

Journal: Bioinformatics (Oxford, England)
Published: April 11, 2024

Mesothelioma survival prediction based on a six-gene transcriptomic signature.

Mesothelioma survival prediction based on a six-gene transcriptomic signature.

Journal: iScience
Published: March 14, 2024

Coupling of response biomarkers between tumor and peripheral blood in patients undergoing chemoimmunotherapy.

Coupling of response biomarkers between tumor and peripheral blood in patients undergoing chemoimmunotherapy.

Journal: Cell reports. Medicine
Published: December 26, 2023

UV1 telomerase vaccine with ipilimumab and nivolumab as second line treatment for pleural mesothelioma - A phase II randomised trial.

UV1 telomerase vaccine with ipilimumab and nivolumab as second line treatment for pleural mesothelioma - A phase II randomised trial.

Journal: European journal of cancer (Oxford, England : 1990)
Published: December 05, 2023

Time-course RNAseq data of murine AB1 mesothelioma and Renca renal cancer following immune checkpoint therapy.

Time-course RNAseq data of murine AB1 mesothelioma and Renca renal cancer following immune checkpoint therapy.

Journal: Scientific data
Published: June 20, 2023

Comprehensive Testing of Chemotherapy and Immune Checkpoint Blockade in Preclinical Cancer Models Identifies Additive Combinations.

Comprehensive Testing of Chemotherapy and Immune Checkpoint Blockade in Preclinical Cancer Models Identifies Additive Combinations.

Journal: Frontiers in immunology
Published: February 09, 2022

Temporally restricted activation of IFNβ signaling underlies response to immune checkpoint therapy in mice.

Temporally restricted activation of IFNβ signaling underlies response to immune checkpoint therapy in mice.

Journal: Nature communications
Published: September 10, 2021

Immune checkpoint inhibitor therapy for malignant pleural mesothelioma.

Immune checkpoint inhibitor therapy for malignant pleural mesothelioma.

Journal: Lung cancer (Amsterdam, Netherlands)
Published: September 10, 2021
Showing 1-12 of 18

Last Updated: 09/26/2026